サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1166124

抗菌剤感受性試験の世界市場：成長、将来の見通し、競合分析（2022年～2030年）

Antimicrobial Susceptibility Test Market - Growth, Future Prospects and Competitive Analysis, 2022 - 2030
出版日: | 発行: Acute Market Reports | ページ情報: 英文 120 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
抗菌剤感受性試験の世界市場：成長、将来の見通し、競合分析（2022年～2030年）
出版日: 2022年08月01日
発行: Acute Market Reports
ページ情報: 英文 120 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の抗菌剤感受性試験の市場規模は、2021年に28億8,542万米ドルで、今後4.7％のCAGRで成長し、2030年には43億5,468万米ドルに達すると予測されています。感染症の増加やスーパー耐性菌への感染の脅威が、抗菌剤感受性市場の成長を後押ししています。また、多様な検査キットの入手可能性と、感染症に対する健康意識の高まりは、早期スクリーニングにつながり、試験やキットの市場成長を促しています。

当レポートでは、世界の抗菌剤感受性試験市場について調査分析し、事業の見通しや市場の促進要因・抑制要因、課題や機会、セグメント別・地域別の市場分析、企業プロファイルなど、体系的な情報を提供しています。

目次

第1章 序文

  • レポートの説明
    • レポートの目的
    • 対象者
    • 主な製品
  • 市場セグメンテーション
  • 調査手法
    • フェーズI：2次調査
    • フェーズII：1次調査
    • フェーズIII：専門家による審査
    • 前提条件
    • 採用されたアプローチ

第2章 エグゼクティブサマリー

  • 市場のスナップショット
  • 世界の抗菌剤感受性試験市場：製品別（2021年）
  • 世界の抗菌剤感受性試験市場：方法別（2021年）
  • 世界の抗菌剤感受性試験市場：試験別（2021年）
  • 世界の抗菌剤感受性試験市場：用途別（2021年）
  • 世界の抗菌剤感受性試験市場：地域別（2021年）
  • COVID-19の影響
  • 魅力的な投資提案：地域別（2021年）
  • 競合分析
    • 主要ベンダーの市場ポジショニング
    • ベンダーが採用する戦略
    • 主要な業界戦略

第3章 抗菌剤感受性試験市場：事業の見通しと市場力学

  • イントロダクション
  • 市場価値（2020年～2030年）
  • 市場力学
    • 市場促進要因
    • 市場抑制要因
    • 主な課題
    • 主な機会
  • 促進要因と抑制要因の影響分析
  • シーソー分析
  • ポーターのファイブフォースモデル
  • PESTEL分析

第4章 抗菌剤感受性試験市場：製品別（2020～2030年）

  • 市場概要
  • 成長と収益分析：2021年/2030年
  • 市場セグメンテーション
    • 培地
    • 自動試験システム
    • 試験とキット

第5章 抗菌剤感受性試験市場：方法別（2020～2030年）

  • 市場概要
  • 成長と収益分析：2021年/2030年
  • 市場セグメンテーション
    • 迅速自動化法
    • 液体希釈法
    • ディスク拡散法
    • 勾配拡散法
    • 分子試験法

第6章 抗菌剤感受性試験市場：試験別（2020～2030年）

  • 市場概要
  • 成長と収益分析：2021年/2030年
  • 市場セグメンテーション
    • 抗真菌性
    • 抗菌
    • 駆虫薬

第7章 抗菌剤感受性試験市場：用途別（2020年～2030年）

  • 市場概要
  • 成長と収益分析：2021年/2030年
  • 市場セグメンテーション
    • 臨床診断
    • 創薬と開発

第8章 北米の抗菌剤感受性試験市場（2020年～2030年）

  • 市場概要
  • 製品別
  • 方法別
  • 試験別
  • 用途別
  • 地域別
    • 北米

第9章 英国・欧州連合の抗菌剤感受性試験市場（2020年～2030年）

  • 市場概要
  • 製品別
  • 方法別
  • 試験別
  • 用途別
  • 地域別
    • 英国・欧州連合

第10章 アジア太平洋地域の抗菌剤感受性試験市場（2020～2030年）

  • 市場概要
  • 製品別
  • 方法別
  • 試験別
  • 用途別
  • 地域別
    • アジア太平洋地域

第11章 ラテンアメリカの抗菌剤感受性試験市場（2020年～2030年）

  • 市場概要
  • 製品別
  • 方法別
  • 試験別
  • 用途別
  • 地域別
    • ラテンアメリカ

第12章 中東・アフリカの抗菌剤感受性試験市場（2020年～2030年）

  • 市場概要
  • 製品別
  • 方法別
  • 試験別
  • 用途別
  • 地域別
    • 中東・アフリカ

第13章 企業プロファイル

  • Alifax Holding S.p.A.
  • Bio-Rad Laboratories, Inc.
  • bioMerieux
  • Biotron Healthcare
  • Becton Dickinson & Company
  • Danaher Corporation
  • HiMedia Laboratories
  • Merck Group
  • Synbiosis
  • Thermo Fisher Scientific, Inc.
図表

List of Tables

  • TABLE 1 Global Antimicrobial Susceptibility Test Market By Product, 2020-2030, USD (Million)
  • TABLE 2 Global Antimicrobial Susceptibility Test Market By Method, 2020-2030, USD (Million)
  • TABLE 3 Global Antimicrobial Susceptibility Test Market By Test, 2020-2030, USD (Million)
  • TABLE 4 Global Antimicrobial Susceptibility Test Market By Application, 2020-2030, USD (Million)
  • TABLE 5 North America Antimicrobial Susceptibility Test Market By Product, 2020-2030, USD (Million)
  • TABLE 6 North America Antimicrobial Susceptibility Test Market By Method, 2020-2030, USD (Million)
  • TABLE 7 North America Antimicrobial Susceptibility Test Market By Test, 2020-2030, USD (Million)
  • TABLE 8 North America Antimicrobial Susceptibility Test Market By Application, 2020-2030, USD (Million)
  • TABLE 9 UK and European Union Antimicrobial Susceptibility Test Market By Product, 2020-2030, USD (Million)
  • TABLE 10 UK and European Union Antimicrobial Susceptibility Test Market By Method, 2020-2030, USD (Million)
  • TABLE 11 UK and European Union Antimicrobial Susceptibility Test Market By Test, 2020-2030, USD (Million)
  • TABLE 12 UK and European Union Antimicrobial Susceptibility Test Market By Application, 2020-2030, USD (Million)
  • TABLE 13 Asia Pacific Antimicrobial Susceptibility Test Market By Product, 2020-2030, USD (Million)
  • TABLE 14 Asia Pacific Antimicrobial Susceptibility Test Market By Method, 2020-2030, USD (Million)
  • TABLE 15 Asia Pacific Antimicrobial Susceptibility Test Market By Test, 2020-2030, USD (Million)
  • TABLE 16 Asia Pacific Antimicrobial Susceptibility Test Market By Application, 2020-2030, USD (Million)
  • TABLE 17 Latin America Antimicrobial Susceptibility Test Market By Product, 2020-2030, USD (Million)
  • TABLE 18 Latin America Antimicrobial Susceptibility Test Market By Method, 2020-2030, USD (Million)
  • TABLE 19 Latin America Antimicrobial Susceptibility Test Market By Test, 2020-2030, USD (Million)
  • TABLE 20 Latin America Antimicrobial Susceptibility Test Market By Application, 2020-2030, USD (Million)
  • TABLE 21 Middle East and Africa Antimicrobial Susceptibility Test Market By Product, 2020-2030, USD (Million)
  • TABLE 22 Middle East and Africa Antimicrobial Susceptibility Test Market By Method, 2020-2030, USD (Million)
  • TABLE 23 Middle East and Africa Antimicrobial Susceptibility Test Market By Test, 2020-2030, USD (Million)
  • TABLE 24 Middle East and Africa Antimicrobial Susceptibility Test Market By Application, 2020-2030, USD (Million)

List of Figures

  • FIG. 1 Global Antimicrobial Susceptibility Test Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Antimicrobial Susceptibility Test Market: Quality Assurance
  • FIG. 5 Global Antimicrobial Susceptibility Test Market, By Product, 2021
  • FIG. 6 Global Antimicrobial Susceptibility Test Market, By Method, 2021
  • FIG. 7 Global Antimicrobial Susceptibility Test Market, By Test, 2021
  • FIG. 8 Global Antimicrobial Susceptibility Test Market, By Application, 2021
  • FIG. 9 Global Antimicrobial Susceptibility Test Market, By Geography, 2021
  • FIG. 10 Global Antimicrobial Susceptibility Test Market, By Product, 2021 Vs 2030, %
  • FIG. 11 Global Antimicrobial Susceptibility Test Market, By Method, 2021 Vs 2030, %
  • FIG. 12 Global Antimicrobial Susceptibility Test Market, By Test, 2021 Vs 2030, %
  • FIG. 13 Global Antimicrobial Susceptibility Test Market, By Application, 2021 Vs 2030, %
  • FIG. 14 U.S. Antimicrobial Susceptibility Test Market (US$ Million), 2020 - 2030
  • FIG. 15 Canada Antimicrobial Susceptibility Test Market (US$ Million), 2020 - 2030
  • FIG. 16 Rest of North America Antimicrobial Susceptibility Test Market (US$ Million), 2020 - 2030
  • FIG. 17 UK Antimicrobial Susceptibility Test Market (US$ Million), 2020 - 2030
  • FIG. 18 Germany Antimicrobial Susceptibility Test Market (US$ Million), 2020 - 2030
  • FIG. 19 Spain Antimicrobial Susceptibility Test Market (US$ Million), 2020 - 2030
  • FIG. 20 Italy Antimicrobial Susceptibility Test Market (US$ Million), 2020 - 2030
  • FIG. 21 France Antimicrobial Susceptibility Test Market (US$ Million), 2020 - 2030
  • FIG. 22 Rest of Europe Antimicrobial Susceptibility Test Market (US$ Million), 2020 - 2030
  • FIG. 23 China Antimicrobial Susceptibility Test Market (US$ Million), 2020 - 2030
  • FIG. 24 Japan Antimicrobial Susceptibility Test Market (US$ Million), 2020 - 2030
  • FIG. 25 India Antimicrobial Susceptibility Test Market (US$ Million), 2020 - 2030
  • FIG. 26 Australia Antimicrobial Susceptibility Test Market (US$ Million), 2020 - 2030
  • FIG. 27 South Korea Antimicrobial Susceptibility Test Market (US$ Million), 2020 - 2030
  • FIG. 28 Rest of Asia Antimicrobial Susceptibility Test Market (US$ Million), 2020 - 2030
  • FIG. 29 Brazil Antimicrobial Susceptibility Test Market (US$ Million), 2020 - 2030
  • FIG. 30 Mexico Antimicrobial Susceptibility Test Market (US$ Million), 2020 - 2030
  • FIG. 31 Rest of Latin America Antimicrobial Susceptibility Test Market (US$ Million), 2020 - 2030
  • FIG. 32 GCC Antimicrobial Susceptibility Test Market (US$ Million), 2020 - 2030
  • FIG. 33 Africa Antimicrobial Susceptibility Test Market (US$ Million), 2020 - 2030
  • FIG. 34 Rest of Middle East and Africa Antimicrobial Susceptibility Test Market (US$ Million), 2020 - 2030
目次
Product Code: 138463-08-22

Industry Outlook

The antimicrobial susceptibility test market had market size of US$ 2885.42 Mn in 2021 and will grow at a CAGR 4.7% and is anticipated to reach US$ 4354.68 Mn in 2030. World Health Organization (WHO) has stipulated stringent guidelines to life science industry and agriculturists to judiciously use antibiotics. Rising prevalence of infectious disease and looming threat of superbug infection drives the antimicrobial susceptibility market growth.

"Availability of diverse range of test kits and easy interpretation propel its market growth"

Tests and Kits are presently reigning the product segment for antimicrobial susceptibility test market. Availability of diverse range of test kits and increasing health awareness regarding infectious disease resulting in early screening drive the tests and kits market growth. They are available as point of care diagnostic kits where in interpretation of results are quick and product is highly reliable and cost saving. There will be burgeoning requirement for culture media on account of flourishing biopharmaceutical industry and preservation of important cell lines and culture having therapeutic significance.

Antimicrobial Susceptibility Test Market

"Increasing demand from clinical and epidemiology applications drive the disk diffusion method"

In the current scenario the disk diffusion method lead the method segment for antimicrobial susceptibility test market owing to its ability to determine the therapeutic efficacy and sensitivity of antibiotics towards different strains of bacteria. Increasing demand from clinical and epidemiological applications drive the market growth for disk diffusion method. Broth dilution method is gaining huge traction from food industry segment due to its potential to detect infection caused by microbes such as E.coli and Enterococcus.

"Rising prevalence of infectious disease and increasing number of patients suffering with antimicrobial resistance propel the antibacterial test market growth"

In the present scenario antibacterial test are dominating the test segment for antimicrobial susceptibility test market. The primary factors responsible for its dominance are rising prevalence of bacterial infection and increasing number of patients suffering with antimicrobial resistance. Scientist are striving earnestly to develop broad spectrum antibiotics. Antiparasitic tests will gain huge traction during the forecast period on account of huge health burden caused by parasitic infections such as malaria, dengue and encephalitis etc.

"Increasing public health awareness regarding infectious disease propel the clinical diagnosis market growth"

Clinical diagnosis is currently leading the application segment for antimicrobial susceptibility test market. The major factors that propel the clinical diagnosis market growth are increasing public health awareness regarding infectious disease resulting in early screening. Huge investment spend by government healthcare agencies worldwide to provide effective diagnosis and precise treatment to curb the diagnosed infection. Drug discovery and development will showcase positive growth owing to the increasing threat caused by antibiotic resistance and rising demand for vaccines and biologics as a preventive measure against deadly infections.

"Rising prevalence of bacterial infection and increasing number of cases pertaining to antibiotic resistance will support the market growth in Asia Pacific region"

North America is leading the regional segment for antimicrobial susceptibility test market. According to the latest research citing presented by Center for Disease Control and Prevention (CDC) annually 2 million U.S. citizens are diagnosed with infectious disease resulting in death of approximately 25,000 people. Existence of well-developed healthcare infrastructure drive the market growth in North America. Supportive regulatory environment provided by European Medical Agency (EMA) and looming threat of antimicrobial resistance drive the market growth in Europe region. Asia Pacific serves as a lucrative market on account of rising prevalence of bacterial infection and burgeoning requirement for broad spectrum antibiotics to curb the spread of infectious diseases.

Pharmaceutical companies providing diagnostic kits for antimicrobial susceptibility test are Alifax Holding S.p.A., Bio-Rad Laboratories, Inc., bioMerieux, Biotron Healthcare, Becton Dickinson & Company, Danaher Corporation, HiMedia, Laboratories, Merck Group, Synbiosis and Thermo Fisher Scientific, Inc.

Historical & Forecast Period

This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Antimicrobial Susceptibility Test market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report

Micro and macro environment factors that are currently influencing the Antimicrobial Susceptibility Test market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Product

Culture Media

Automated Test Systems

Tests and Kits

Method

Rapid Automated Method

Broth Dilution Method

Disk Diffusion Method

Gradient Diffusion Method

Molecular Testing Method

Test

Antifungal

Antibacterial

Antiparasitic

Application

Clinical Diagnosis

Drug Discovery & Development

Region Segment (2020-2030; US$ Million)

North America

U.S.

Canada

Rest of North America

UK and European Union

UK

Germany

Spain

Italy

France

Rest of Europe

Asia Pacific

China

Japan

India

Australia

South Korea

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

Middle East and Africa

GCC

Africa

Rest of Middle East and Africa

Global Impact of Covid-19 Segment (2020-2021; US$ Million )

Pre Covid-19 situation

Post Covid-19 situation

Key questions answered in this report

What are the key micro and macro environmental factors that are impacting the growth of Antimicrobial Susceptibility Test market?

What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?

Estimated forecast and market projections up to 2030.

Which segment accounts for the fastest CAGR during the forecast period?

Which market segment holds a larger market share and why?

Are low and middle-income economies investing in the Antimicrobial Susceptibility Test market?

Which is the largest regional market for Antimicrobial Susceptibility Test market?

What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?

Which are the key trends driving Antimicrobial Susceptibility Test market growth?

Who are the key competitors and what are their key strategies to enhance their market presence in the Antimicrobial Susceptibility Test market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Antimicrobial Susceptibility Test Market
  • 2.2. Global Antimicrobial Susceptibility Test Market, By Product, 2021 (US$ Million)
  • 2.3. Global Antimicrobial Susceptibility Test Market, By Method, 2021 (US$ Million)
  • 2.4. Global Antimicrobial Susceptibility Test Market, By Test, 2021 (US$ Million)
  • 2.5. Global Antimicrobial Susceptibility Test Market, By Application, 2021 (US$ Million)
  • 2.6. Global Antimicrobial Susceptibility Test Market, By Geography, 2021 (US$ Million)
  • 2.7. Impact of Covid 19
  • 2.8. Attractive Investment Proposition by Geography, 2021
  • 2.9. Competitive Analysis
    • 2.9.1. Market Positioning of Key Antimicrobial Susceptibility Test Market Vendors
    • 2.9.2. Strategies Adopted by Antimicrobial Susceptibility Test Market Vendors
    • 2.9.3. Key Industry Strategies

3. Antimicrobial Susceptibility Test Market: Business Outlook & Market Dynamics

  • 3.1. Introduction
  • 3.2. Global Antimicrobial Susceptibility Test Market Value, 2020 - 2030, (US$ Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers
    • 3.3.2. Market Restraints
    • 3.3.3. Key Challenges
    • 3.3.4. Key Opportunities
  • 3.4. Impact Analysis of Drivers and Restraints
  • 3.5. See-Saw Analysis
  • 3.6. Porter's Five Force Model
    • 3.6.1. Supplier Power
    • 3.6.2. Buyer Power
    • 3.6.3. Threat Of Substitutes
    • 3.6.4. Threat Of New Entrants
    • 3.6.5. Competitive Rivalry
  • 3.7. PESTEL Analysis
    • 3.7.1. Political Landscape
    • 3.7.2. Economic Landscape
    • 3.7.3. Technology Landscape
    • 3.7.4. Legal Landscape
    • 3.7.5. Social Landscape

4. Antimicrobial Susceptibility Test Market: By Product, 2020-2030, USD (Million)

  • 4.1. Market Overview
  • 4.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 4.3. Market Segmentation
    • 4.3.1. Culture Media
    • 4.3.2. Automated Test Systems
    • 4.3.3. Tests and Kits

5. Antimicrobial Susceptibility Test Market: By Method, 2020-2030, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 5.3. Market Segmentation
    • 5.3.1. Rapid Automated Method
    • 5.3.2. Broth Dilution Method
    • 5.3.3. Disk Diffusion Method
    • 5.3.4. Gradient Diffusion Method
    • 5.3.5. Molecular Testing Method

6. Antimicrobial Susceptibility Test Market: By Test, 2020-2030, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 6.3. Market Segmentation
    • 6.3.1. Antifungal
    • 6.3.2. Antibacterial
    • 6.3.3. Antiparasitic

7. Antimicrobial Susceptibility Test Market: By Application, 2020-2030, USD (Million)

  • 7.1. Market Overview
  • 7.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 7.3. Market Segmentation
    • 7.3.1. Clinical Diagnosis
    • 7.3.2. Drug Discovery & Development

8. North America Antimicrobial Susceptibility Test Market, 2020-2030, USD (Million)

  • 8.1. Market Overview
  • 8.2. Antimicrobial Susceptibility Test Market: By Product, 2020-2030, USD (Million)
  • 8.3. Antimicrobial Susceptibility Test Market: By Method, 2020-2030, USD (Million)
  • 8.4. Antimicrobial Susceptibility Test Market: By Test, 2020-2030, USD (Million)
  • 8.5. Antimicrobial Susceptibility Test Market: By Application, 2020-2030, USD (Million)
  • 8.6.Antimicrobial Susceptibility Test Market: By Region, 2020-2030, USD (Million)
    • 8.6.1.North America
      • 8.6.1.1. U.S.
      • 8.6.1.2. Canada
      • 8.6.1.3. Rest of North America

9. UK and European Union Antimicrobial Susceptibility Test Market, 2020-2030, USD (Million)

  • 9.1. Market Overview
  • 9.2. Antimicrobial Susceptibility Test Market: By Product, 2020-2030, USD (Million)
  • 9.3. Antimicrobial Susceptibility Test Market: By Method, 2020-2030, USD (Million)
  • 9.4. Antimicrobial Susceptibility Test Market: By Test, 2020-2030, USD (Million)
  • 9.5. Antimicrobial Susceptibility Test Market: By Application, 2020-2030, USD (Million)
  • 9.6.Antimicrobial Susceptibility Test Market: By Region, 2020-2030, USD (Million)
    • 9.6.1.UK and European Union
      • 9.6.1.1. UK
      • 9.6.1.2. Germany
      • 9.6.1.3. Spain
      • 9.6.1.4. Italy
      • 9.6.1.5. France
      • 9.6.1.6. Rest of Europe

10. Asia Pacific Antimicrobial Susceptibility Test Market, 2020-2030, USD (Million)

  • 10.1. Market Overview
  • 10.2. Antimicrobial Susceptibility Test Market: By Product, 2020-2030, USD (Million)
  • 10.3. Antimicrobial Susceptibility Test Market: By Method, 2020-2030, USD (Million)
  • 10.4. Antimicrobial Susceptibility Test Market: By Test, 2020-2030, USD (Million)
  • 10.5. Antimicrobial Susceptibility Test Market: By Application, 2020-2030, USD (Million)
  • 10.6.Antimicrobial Susceptibility Test Market: By Region, 2020-2030, USD (Million)
    • 10.6.1.Asia Pacific
      • 10.6.1.1. China
      • 10.6.1.2. Japan
      • 10.6.1.3. India
      • 10.6.1.4. Australia
      • 10.6.1.5. South Korea
      • 10.6.1.6. Rest of Asia Pacific

11. Latin America Antimicrobial Susceptibility Test Market, 2020-2030, USD (Million)

  • 11.1. Market Overview
  • 11.2. Antimicrobial Susceptibility Test Market: By Product, 2020-2030, USD (Million)
  • 11.3. Antimicrobial Susceptibility Test Market: By Method, 2020-2030, USD (Million)
  • 11.4. Antimicrobial Susceptibility Test Market: By Test, 2020-2030, USD (Million)
  • 11.5. Antimicrobial Susceptibility Test Market: By Application, 2020-2030, USD (Million)
  • 11.6.Antimicrobial Susceptibility Test Market: By Region, 2020-2030, USD (Million)
    • 11.6.1.Latin America
      • 11.6.1.1. Brazil
      • 11.6.1.2. Mexico
      • 11.6.1.3. Rest of Latin America

12. Middle East and Africa Antimicrobial Susceptibility Test Market, 2020-2030, USD (Million)

  • 12.1. Market Overview
  • 12.2. Antimicrobial Susceptibility Test Market: By Product, 2020-2030, USD (Million)
  • 12.3. Antimicrobial Susceptibility Test Market: By Method, 2020-2030, USD (Million)
  • 12.4. Antimicrobial Susceptibility Test Market: By Test, 2020-2030, USD (Million)
  • 12.5. Antimicrobial Susceptibility Test Market: By Application, 2020-2030, USD (Million)
  • 12.6.Antimicrobial Susceptibility Test Market: By Region, 2020-2030, USD (Million)
    • 12.6.1.Middle East and Africa
      • 12.6.1.1. GCC
      • 12.6.1.2. Africa
      • 12.6.1.3. Rest of Middle East and Africa

13. Company Profile

  • 13.1. Alifax Holding S.p.A.
    • 13.1.1. Company Overview
    • 13.1.2. Financial Performance
    • 13.1.3. Product Portfolio
    • 13.1.4. Strategic Initiatives
  • 13.2. Bio-Rad Laboratories, Inc.
    • 13.2.1. Company Overview
    • 13.2.2. Financial Performance
    • 13.2.3. Product Portfolio
    • 13.2.4. Strategic Initiatives
  • 13.3. bioMerieux
    • 13.3.1. Company Overview
    • 13.3.2. Financial Performance
    • 13.3.3. Product Portfolio
    • 13.3.4. Strategic Initiatives
  • 13.4. Biotron Healthcare
    • 13.4.1. Company Overview
    • 13.4.2. Financial Performance
    • 13.4.3. Product Portfolio
    • 13.4.4. Strategic Initiatives
  • 13.5. Becton Dickinson & Company
    • 13.5.1. Company Overview
    • 13.5.2. Financial Performance
    • 13.5.3. Product Portfolio
    • 13.5.4. Strategic Initiatives
  • 13.6. Danaher Corporation
    • 13.6.1. Company Overview
    • 13.6.2. Financial Performance
    • 13.6.3. Product Portfolio
    • 13.6.4. Strategic Initiatives
  • 13.7. HiMedia Laboratories
    • 13.7.1. Company Overview
    • 13.7.2. Financial Performance
    • 13.7.3. Product Portfolio
    • 13.7.4. Strategic Initiatives
  • 13.8. Merck Group
    • 13.8.1. Company Overview
    • 13.8.2. Financial Performance
    • 13.8.3. Product Portfolio
    • 13.8.4. Strategic Initiatives
  • 13.9. Synbiosis
    • 13.9.1. Company Overview
    • 13.9.2. Financial Performance
    • 13.9.3. Product Portfolio
    • 13.9.4. Strategic Initiatives
  • 13.10. Thermo Fisher Scientific, Inc.
    • 13.10.1. Company Overview
    • 13.10.2. Financial Performance
    • 13.10.3. Product Portfolio
    • 13.10.4. Strategic Initiatives